nitrites has been researched along with alpha-synuclein in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Sidhu, A; Wersinger, C | 1 |
| Block, ML; Hong, JS; Miller, DS; Pei, Z; Wang, T; Wilson, B; Wu, X; Zhang, J; Zhang, W; Zhou, Y | 1 |
| Chung, KC; Kim, J; Lee, CH; Lee, HJ; Lee, ST; Oh, YJ; Paik, SR; Park, SM; Sung, JY; Um, JW | 1 |
| Combs, CK; Murphy, EJ; Rojanathammanee, L | 1 |
| He, R; Liu, Y; Qiang, M; Wei, Y | 1 |
| Adem, A; Azimullah, S; Beiram, R; Jalal, FY; Jayaraj, RL; Meeran, MFN; Ojha, SK | 1 |
| Chaturvedi, S; Gupta, P; Mishra, A; Singh, A; Singh, S; Tiwari, S; Wahajuddin, M | 1 |
7 other study(ies) available for nitrites and alpha-synuclein
| Article | Year |
|---|---|
Differential cytotoxicity of dopamine and H2O2 in a human neuroblastoma divided cell line transfected with alpha-synuclein and its familial Parkinson's disease-linked mutants.
Topics: alpha-Synuclein; Blotting, Western; Cell Death; Dopamine; Humans; Hydrogen Peroxide; Mutation; Nerve Tissue Proteins; Neuroblastoma; Nitrites; Parkinson Disease; Synucleins; Transfection; Tumor Cells, Cultured | 2003 |
Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.
Topics: alpha-Synuclein; Animals; Astrocytes; Brain; Cells, Cultured; Dinoprostone; Dopamine; Embryo, Mammalian; Enzyme Activation; gamma-Aminobutyric Acid; Humans; Immunohistochemistry; Mesencephalon; Mice; Mice, Knockout; Microglia; NADPH Oxidases; Nerve Degeneration; Neuroglia; Neurons; Nitric Oxide; Nitrites; Oxidative Stress; Parkinson Disease; Phagocytosis; Polymers; Rats; Rats, Inbred F344; Reactive Oxygen Species; Recombinant Proteins; Substantia Nigra; Tritium; Tumor Necrosis Factor-alpha; Tyrosine 3-Monooxygenase | 2005 |
Proteolytic cleavage of extracellular secreted {alpha}-synuclein via matrix metalloproteinases.
Topics: alpha-Synuclein; Alzheimer Disease; Amyloid beta-Peptides; Animals; Blotting, Western; Catalytic Domain; Cell Line, Tumor; Cell Survival; Coloring Agents; Culture Media; Dopamine; Humans; Immunohistochemistry; Insecta; Kinetics; Male; Matrix Metalloproteinase 3; Matrix Metalloproteinases; Nerve Tissue Proteins; Nitric Oxide; Nitrites; Oxidopamine; Oxygen; Parkinson Disease; Protein Binding; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Substantia Nigra; Synucleins; Tetrazolium Salts; Thiazoles; Time Factors; Transfection | 2005 |
Expression of mutant alpha-synuclein modulates microglial phenotype in vitro.
Topics: alpha-Synuclein; Animals; Cell Line; Cyclooxygenase 1; Cyclooxygenase 2; Humans; Interleukin-6; Lysosomal-Associated Membrane Protein 1; Lysosomes; Mice; Mice, Inbred C57BL; Microglia; Mutation; Nitrites; Parkinson Disease; Phagocytosis; Phenotype; Phospholipase D; Reactive Nitrogen Species; Tumor Necrosis Factor-alpha | 2011 |
A novel molecular mechanism for nitrated {alpha}-synuclein-induced cell death.
Topics: alpha-Synuclein; Antibodies; Apoptosis; Calcium; Caspase 3; Cell Line, Tumor; Focal Adhesion Protein-Tyrosine Kinases; Humans; Immunoprecipitation; Integrin alpha5beta1; Nitric Oxide; Nitric Oxide Synthase Type II; Nitrites; Polymerization; Recombinant Proteins; Signal Transduction; Tyrosine | 2011 |
Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and Neuroinflammation in a Rat Model of Parkinson's Disease.
Topics: alpha-Synuclein; Animals; Antioxidants; Brain; Catalase; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Dopaminergic Neurons; Glutathione; Inflammation; Inflammation Mediators; Lipid Peroxidation; Lycopodium; Male; Malondialdehyde; Matrix Metalloproteinases; Microglia; Nerve Degeneration; Neuroprotection; Nitric Oxide; Nitric Oxide Synthase Type II; Nitrites; Oxidative Stress; Parkinson Disease; Plant Extracts; Rats, Wistar; Rotenone; Superoxide Dismutase | 2019 |
4-Phenylbutyrate Mitigates the Motor Impairment and Dopaminergic Neuronal Death During Parkinson's Disease Pathology via Targeting VDAC1 Mediated Mitochondrial Function and Astrocytes Activation.
Topics: alpha-Synuclein; Animals; Astrocytes; bcl-2-Associated X Protein; Calcium; Caspase 3; Cytochromes; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Histone Deacetylases; Mitochondria; Motor Disorders; Neuroprotective Agents; Nitrites; Parkinson Disease; Phenylbutyrates; Protein Aggregates; Rats; Tyrosine 3-Monooxygenase; Voltage-Dependent Anion Channel 1 | 2022 |